Rosuvastatin
Back to searchMolecule Structure
Scientific Name
Rosuvastatin
Description of the Drug
Rosuvastatin is an HMG-CoA reductase inhibitor used to lower lipid levels and reduce the risk of cardiovascular disease including myocardial infarction and stroke.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01098
http://www.drugbank.ca/drugs/DB01098
Brand Name(s)
Not Available
Company Owner(s)
Sunshine Lake Pharma Co Ltd, Alkem Laboratories Ltd, Watson Laboratories Inc, Glenmark Pharmaceuticals Sa, Inventia Healthcare Ltd, Torrent Pharmaceuticals Ltd, Althera Pharmaceuticals Llc, Lupin Inc, Accord Healthcare Inc, Aurobindo Pharma Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| HMG-CoA reductase | SINGLE PROTEIN | INHIBITOR | CHEMBL402 |
Clinical Trial(s)
Unichem Links
| Atlas | Rosuvastatin | |||
| SureChEMBL | SCHEMBL2520 | |||
| Human Metabolome Database | HMDB0015230 | |||
| DrugBank | DB01098 | |||
| PubChem: Thomson Pharma | 14834808 | 14810118 | ||
| PubChem | 446157 | |||
| LINCS | LSM-43032 | |||
| Nikkaji | J3.118.169K | |||
| BindingDB | 18372 | |||
| EPA CompTox Dashboard | DTXSID8048492 | |||
| DrugCentral | 2406 | |||
| Brenda | 8562 | 229905 | 229904 | |
| Guide to Pharmacology | 2954 | |||
| rxnorm | ROSUVASTATIN CALCIUM | EZALLOR | ROSUVASTATIN | CRESTOR |
| ChEBI | 38545 | |||
| ZINC | ZINC000001535101 |
